GLSHQ (Gelesis Holdings) OCF Yield %: 0.00 (As of Jun. 29, 2026)


What is Gelesis Holdings OCF Yield %?

Gelesis Holdings GLSHQ -99.00% OCF Yield % is 0.00 as of Jun. 29, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Gelesis Holdings's Trailing 12-Month Cash Flow from Operations is $-46.04 Mil, and Market Cap is $0.00 Mil. Therefore, Gelesis Holdings's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Gelesis Holdings's OCF Yield % or its related term are showing as below:


During the past 2 years, the highest OCF Yield % of Gelesis Holdings was 9907300.00%. The lowest was -8010600.00%. And the median was %.

GLSHQ's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -8.23
* Ranked among companies with meaningful OCF Yield % only.

Gelesis Holdings's OCF Margin % for the quarter that ended in Jun. 2023 was %.

Gelesis Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Gelesis Holdings OCF Yield % Related Terms

Gelesis Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings OCF Yield % Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
OCF Yield %
0.00 -365.03

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.32 -110.03 -305.73 -291.54 93.48

GLSHQ vs RBSH, PPCB, RGMP: OCF Yield % Comparison

For the Biotechnology subindustry, Gelesis Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's OCF Yield % falls into.


Gelesis Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Gelesis Holdings's OCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-77.728 / 21.29358
=-365.03%

Gelesis Holdings's annualized OCF Yield % for the quarter that ended in Jun. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0.617 * 4 / 2.64006
=93.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Gelesis Holdings (GLSHQ) has a OCF Yield % of 0.00 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' OCF Yield % too high?
Gelesis Holdings' current OCF Yield % is 0.00.
How does Gelesis Holdings' OCF Yield % compare to RBSH and PPCB?
Gelesis Holdings' OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current OCF Yield % is 0.00 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.